X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Cardiovascular Therapeutics

期刊標題檢索 CARDIOVASC THER 最新評論: How long does it take to get a response? It's been pending for five we... (2023-10-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Cardiovascular Therapeutics]您好,您是該頁面的第 29199 位訪客。

期刊簡介
期刊名稱Cardiovascular Therapeutics Cardiovascular Therapeutics
LetPub Score
6.2
50 ratings
Rate

Reputation
7.5

Influence
4.8

Speed
8.4

期刊簡稱CARDIOVASC THER
ISSN1755-5914
E-ISSN1755-5922
h-index39
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.600.7690.723
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q195 / 387
Category: Medicine
Subcategory: Pharmacology (medical)
Q287 / 272
Category: Medicine
Subcategory: Pharmacology
Q2133 / 313

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.

Subject areas include (but are by no means limited to):

Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.
官方網站https://www.hindawi.com/journals/cdtp
在線稿件提交https://mc.manuscriptcentral.com/cdr
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年2008
每年文章數34每年文章數趨勢
黃金OA百分比99.28%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ257/220
PHARMACOLOGY & PHARMACYSCIEQ2105/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-5914%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 6 Month(s)
競爭力 *來自作者的數據: About 95%
參考鏈接
相關期刊 【Cardiovascular Therapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews CardiologyH-index: 105

    CiteScore: 53.10
    EUROPEAN HEART JOURNALH-index: 265

    CiteScore: 39.30
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYH-index: 394

    CiteScore: 42.70
    EUROPEAN JOURNAL OF HEART FAILUREH-index: 119

    CiteScore: 27.30
    CARDIOVASCULAR RESEARCHH-index: 202

    CiteScore: 21.50
    Circulation-Arrhythmia and ElectrophysiologyH-index: 87

    CiteScore: 13.70
    EUROPACEH-index: 92

    CiteScore: 10.30
    Circulation-Heart FailureH-index: 88

    CiteScore: 12.90
    BASIC RESEARCH IN CARDIOLOGYH-index: 86

    CiteScore: 16.30
    TRENDS IN CARDIOVASCULAR MEDICINEH-index: 92

    CiteScore: 18.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Cardiology110009
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY105865
    CARDIOVASCULAR RESEARCH104338
    EUROPEAN HEART JOURNAL65369
    HEART57446
    CARDIOLOGY52040
    BASIC RESEARCH IN CARDIOLOGY48203
    AMERICAN JOURNAL OF CARDIOLOGY46517
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY44577
    CLINICAL CARDIOLOGY39747
  •  

    Cardiovascular Therapeutics Cardiovascular Therapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Cardiovascular Therapeutics] 的評論撰寫評論
作者: 狮吼冬冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-20 10:49:17 評論於
How long does it take to get a response? It's been pending for five weeks~
(0) 讚! | 狮吼冬冬

作者: 绮烟mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-06 19:02:38 評論於
Assigned, the reviewers have been looking for 10 days and still haven't found it
(0) 讚! | 绮烟mio

作者: Yehudi More


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-05 15:05:20 評論於
Isn't this normal? Once it's divided, it'll be quick
(0) 讚! | Yehudi More

作者: 绮烟mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-11 18:19:31 評論於
How long does it take to allocate?
(0) 讚! | 绮烟mio

作者: 深渊学林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-23 23:41:04 評論於
Have you been assigned an editor? It's been 12 days and I still haven't been assigned an editor
(0) 讚! | 深渊学林

作者: xzj2022


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-07 09:06:14 評論於
Is this journal invitation only? Why can't I find a submission section? After logging in, it shows "This site only accepts invited submissions."
(0) 讚! | xzj2022

作者: 北国东硕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-19 08:21:21 評論於
Heavy research focus: Cardiovascular experience sharing: It's been 5 days since submission, and the editor hasn't been assigned yet. Is this situation common?
(0) 讚! | 北国东硕

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:18:10 評論於
The number of corresponding authors for SCI journal papers is not necessarily limited to one, and there is no fixed standard. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if multiple corresponding authors are listed on a paper, the first corresponding author will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements, meaning that the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiments and writing of the paper and is the person whose name appears first in the list of authors. However, in cases where multiple authors collaborate, it is common to have multiple first authors. There is no clear regulation regarding the number of co-first authors, and this is largely dependent on factors such as the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the authors’ institutions. In general, it is common for an SCI paper to have 2-4 first authors
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:35:48 評論於
The corresponding author is the overall responsible person for the research project, responsible for the project's funding, design, writing of articles, and quality control, and responsible for communication with journals during submission, peer review, and the entire publication process
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 10:28:04 評論於
How many corresponding authors/first authors can a journal have?
(0) 讚! | 深渊兴业

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:21:51 評論於
What is a corresponding author?
(0) 讚! | 陶宜三岁啦

作者: 重阳振安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-25 08:47:52 評論於
How long until we start seeing results?
(0) 讚! | 重阳振安

作者: Rodney Toby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-19 09:37:34 評論於
Research focus: Cardiovascular Experiences: pending approval for nearly 2 weeks with no response
(0) 讚! | Rodney Toby

作者: 巴蜀彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-24 10:40:50 評論於
Is pure basic research acceptable?
(0) 讚! | 巴蜀彦露

作者: 北国安阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-24 22:28:47 評論於
I submitted it on October 8th, and received a reply email at the end of October urging for the draft. There was no email reply last Thursday urging for the draft. Now I see the comments and I am very worried!
(0) 讚! | 北国安阳

作者: 青曼酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-15 19:43:45 評論於
Is the magazine going to close down? Not only have there been no updates for nearly five months, but there hasn't been a new article on the magazine's homepage for several months. Are they on a six-month break?
(0) 讚! | 青曼酱大魔王

作者: 缠丝博泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-18 23:10:33 評論於
How long does it take for them to include my submission? I didn't realize that my article for 2019 couldn't be searched after half a day of submission. I also don't understand what's going on with this journal
(0) 讚! | 缠丝博泽

作者: 缠丝博泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-18 14:05:06 評論於
Currently, no articles from 2019 can be retrieved
(0) 讚! | 缠丝博泽

作者: Saxon Sophy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-08-11 16:07:45 評論於
Delay in submission
(0) 讚! | Saxon Sophy

作者: 青曼酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-31 21:44:53 評論於
Is the acceptance rate really only 11%?
(0) 讚! | 青曼酱大魔王

作者: 终幕志永


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-23 22:18:23 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Quarterly, the review process is currently a bit slow. If you are in a hurry, we suggest submitting to another journal
(0) 讚! | 终幕志永

作者: Valiant


領域: 医学
審稿時間: 5.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-23 17:30:44 評論於
Quarterly, now reviewing a bitSlow, more anxious, it is recommended to change to other journals..
(0) 讚! | Valiant

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 10:56:40 評論於
On the rise, optimistic about the future, what do you all think?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 10:11:05 評論於
This journal is now rated 2.5, which is a significant increase from last year. Is there a possibility of reaching 3 points?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 08:30:39 評論於
Research Focus: Cardiovascular
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Cardiovascular Therapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*